Australia, May 3 -- Biohaven Therapeutics Ltd., owns the trademark (2521563) for 'CAPMERQ' till Dec. 23, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations and substances for the treatment of neurological, neuropsychiatric, neurodegenerative, viral, metabolic, obesity, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, osteogenesis, immune system, central nervous system, peripheral nervous system, and voluntary muscle movement related diseases and disorders.]
Type of Mark: Word
Date of Acceptance: Feb. 24
Registration Advertised: May 2
For further details contact Monica Riva Talley ...